T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 10,500 | 4,666 | 4,080 | 2,813 | 119 |
| Cost of Goods | 15,404 | 12,028 | 6,872 | 1,740 | N/A |
| Gross Profit | -4,904 | -7,362 | -2,792 | 1,073 | 119 |
| Operating Expenses | 40,590 | 46,518 | 48,958 | 45,196 | 30,800 |
| Operating Income | -45,090 | -53,852 | -50,878 | -43,383 | -30,681 |
| Interest Expense | 6,682 | 8,907 | 4,098 | 1,967 | 721 |
| Other Income | 619 | 331 | 172 | 60 | 12 |
| Pre-tax Income | -51,153 | -62,428 | -54,804 | -45,290 | -31,390 |
| Net Income Continuous | -51,153 | -62,428 | -54,804 | -45,290 | -31,390 |
| Net Income | $-51,153 | $-62,428 | $-54,804 | $-45,290 | $-31,390 |
| EPS Basic Total Ops | -6,300.00 | -9,700.00 | -10,550.00 | -11,050.00 | -20,750.00 |
| EPS Basic Continuous Ops | -6,306.00 | -9,714.30 | -10,532.75 | -11,045.26 | -18,092.22 |
| EPS Diluted Total Ops | -6,300.00 | -9,700.00 | -10,550.00 | -11,050.00 | -20,750.00 |
| EPS Diluted Continuous Ops | -6,306.00 | -9,714.30 | -10,532.75 | -11,045.26 | -18,092.22 |
| EPS Diluted Before Non-Recurring Items | -6,300.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-42,641 | $-50,912 | $-48,598 | $-41,918 | $-29,990 |